These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23689239)

  • 1. Current status of implementation of self-administration training in various regions of Europe, Canada and the USA in the management of hereditary angioedema.
    Caballero T; Sala-Cunill A; Cancian M; Craig TJ; Neri S; Keith PK; Boccon-Gibod I; Bethune C; Bork K
    Int Arch Allergy Immunol; 2013; 161 Suppl 1():10-6. PubMed ID: 23689239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges of C1-inhibitor concentrate self-administration.
    Boysen HB; Bouillet L; Aygören-Pürsün E
    Int Arch Allergy Immunol; 2013; 161 Suppl 1():21-5. PubMed ID: 23689241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical approach to self-administration of intravenous C1-INH concentrate: a nursing perspective.
    Symons C; Rossi O; Magerl M; Andritschke K
    Int Arch Allergy Immunol; 2013; 161 Suppl 1():17-20. PubMed ID: 23689240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Training hereditary angioedema patients to self-administer intravenous C1 esterase inhibitor concentrate.
    Shapiro RS; Zacek L
    J Infus Nurs; 2014; 37(4):284-90. PubMed ID: 24983261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits.
    Bygum A; Andersen KE; Mikkelsen CS
    Eur J Dermatol; 2009; 19(2):147-51. PubMed ID: 19264579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
    Riedl M
    Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary angioedema treatment options: the availability of new therapies.
    Aberer W
    Ann Med; 2012 Sep; 44(6):523-9. PubMed ID: 22784006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summary of the International Multicenter Prospective Angioedema C1-inhibitor Trials 1 and 2 (IMPACT1 and 2).
    Krassilnikova S; Craig ET; Craig TJ
    Expert Rev Clin Immunol; 2010 May; 6(3):327-34. PubMed ID: 20441418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of recent guidelines and consensus statements on hereditary angioedema therapy with focus on self-administration.
    Cicardi M; Craig TJ; Martinez-Saguer I; Hébert J; Longhurst HJ
    Int Arch Allergy Immunol; 2013; 161 Suppl 1():3-9. PubMed ID: 23689238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in hereditary angioedema self-administration treatment: summary of an International Hereditary Angioedema Expert Meeting.
    Craig TJ
    Int Arch Allergy Immunol; 2013; 161 Suppl 1():26-7. PubMed ID: 23689242
    [No Abstract]   [Full Text] [Related]  

  • 11. Patients perception of self-administrated medication in the treatment of hereditary angioedema.
    Wang A; Fouche A; Craig TJ
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):120-5. PubMed ID: 26118352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of home infusion and self-administration of nanofiltered C1 esterase inhibitor for routine prophylaxis in patients with hereditary angioedema and characterization of a training and support program.
    Gregory C; Landmesser LM; Corrigan L; Mariano D
    J Infus Nurs; 2014; 37(1):29-34. PubMed ID: 24384882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema.
    Petraroli A; Squeglia V; Di Paola N; Barbarino A; Bova M; Spanò R; Marone G; Triggiani M
    Int Arch Allergy Immunol; 2015; 166(4):259-66. PubMed ID: 25924832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients?
    Lunn ML; Santos CB; Craig TJ
    Ann Allergy Asthma Immunol; 2010 Mar; 104(3):211-4. PubMed ID: 20377110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-administration of intravenous C1 esterase inhibitor in hereditary angioedema.
    Rizk C; Karsh J; Santucci S; Yang W
    CMAJ; 2013 Jun; 185(9):791-2. PubMed ID: 23610020
    [No Abstract]   [Full Text] [Related]  

  • 16. Current medical management of hereditary angioedema: follow-up survey of US physicians.
    Riedl MA; Banerji A; Gower R
    J Allergy Clin Immunol Pract; 2015; 3(2):220-7. PubMed ID: 25609328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of the teaching of intravenous self-administration in patients with hereditary angio-oedema.
    Mühlberg H; Ettl N; Magerl M
    Clin Exp Dermatol; 2016 Jun; 41(4):366-71. PubMed ID: 26850568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary angioedema: long-term treatment with one or more injections of C1 inhibitor concentrate per week.
    Bork K; Hardt J
    Int Arch Allergy Immunol; 2011; 154(1):81-8. PubMed ID: 20664282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in hereditary angioedema self-administration treatment: summary of an International Hereditary Angioedema Expert Meeting.
    Craig TJ
    Int Arch Allergy Immunol; 2013; 161 Suppl 1():1-2. PubMed ID: 23689237
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic agents for hereditary angioedema.
    Wuillemin WA
    N Engl J Med; 2011 Jan; 364(1):84-5; author reply 85-6. PubMed ID: 21208117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.